BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, April 21, 2025
Breaking News: Trump administration impacts
Breaking News: Trump administration impacts
Breaking News: Trump administration impacts
Breaking News: Trump administration impacts
Home
»
Topics
» BioWorld Science, Neurology/psychiatric
BioWorld Science, Neurology/psychiatric
RSS
Mediolanum synthesizes AChE inhibitors for Alzheimer's
April 26, 1996
Scopolamine gel available in U.S. for motion sickness
April 26, 1996
Avonex approval imminent
April 26, 1996
New antidepressants disclosed by Yamanouchi
April 26, 1996
Mitsui Seiyaku describes sigma-opioid antagonist
April 26, 1996
Sigma-opioid ligands from ADIR
April 26, 1996
U.S. government claims new antipsychotic compositions
April 26, 1996
IRI-695 for anxiety and depression
April 26, 1996
TAD-93 in preclinical studies for anxiety
April 26, 1996
New 5-HT1D antagonists from Pierre Fabre
April 26, 1996
Previous
1
2
…
2729
2730
2731
2732
2733
2734
2735
2736
2737
2738
2739
2740
Next
RSS